A detailed history of Aaron Wealth Advisors LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Aaron Wealth Advisors LLC holds 460 shares of REGN stock, worth $339,480. This represents 0.06% of its overall portfolio holdings.

Number of Shares
460
Previous 403 14.14%
Holding current value
$339,480
Previous $423,000 14.18%
% of portfolio
0.06%
Previous 0.06%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024

BUY
$1024.09 - $1201.76 $58,373 - $68,500
57 Added 14.14%
460 $483,000
Q2 2024

Jul 22, 2024

BUY
$883.2 - $1071.19 $148,377 - $179,959
168 Added 71.49%
403 $423,000
Q1 2024

Apr 25, 2024

BUY
$902.69 - $993.35 $212,132 - $233,437
235 New
235 $226,000
Q1 2023

May 02, 2023

BUY
$680.49 - $826.97 $168,761 - $205,088
248 New
248 $203,000
Q2 2022

Jul 22, 2022

SELL
$548.35 - $738.84 $48.6 Million - $65.5 Million
-88,699 Closed
0 $0
Q1 2022

May 10, 2022

BUY
$595.12 - $698.43 $52.8 Million - $62 Million
88,699 New
88,699 $127,000

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $79.1B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Aaron Wealth Advisors LLC Portfolio

Follow Aaron Wealth Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aaron Wealth Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aaron Wealth Advisors LLC with notifications on news.